ASLAN003 Uses, Dosage, Side Effects and more
ASLAN003 is under investigation in clinical trial NCT03451084 (A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia).
| Trade Name | ASLAN003 |
| Generic | ASLAN003 |
| Type | |
| Formula | C19H14F2N2O3 |
| Weight | Average: 356.329 Monoisotopic: 356.097248645 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
